SiBionics
PrivateLast Round
Series D
Dec 21, 2022
Total Funding Raised
$196.7M
Company Overview
SiBionics is a medical technology company that develops and markets active implantable medical devices and AI-driven solutions for chronic disease management, including continuous glucose monitoring systems.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Sensors, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SiBionics Comparables
Compare SiBionics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medtrum Technologies | 84% | |
| Abbott Laboratories | 83% | |
| DexCom | 82% |
SiBionics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 21, 2022 | ||||
| Series C Extension | Jan 21, 2022 | ||||
| Series C Extension | May 7, 2021 | ||||
| Series C | Dec 25, 2020 | ||||
| Series B | Oct 1, 2017 |
SiBionics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longmen Capital | Series B |
| Luxin Venture Capital Group Co., Ltd. | Series C Extension, Series C |
| Shenzhen Dachen Caizhi Venture Capital Management | Series C Extension |
| Xingzheng Innovation Capital | Series D |
| Sunshine Insurance Group | Series C |
| Source Code Capital | Series C Extension, Series C |
| CPE | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
Attended the EASD 2025 event to showcase diabetes solutions.
- Sep 22, 2025
Continuous Glucose Monitor (CGM) meets special control criteria for integrated systems.
Recent news
Latest coverage and updates
- attends_eventAug 31, 2026
Sibionics group attended event IDF-WPR 2026 Congress on Aug 31st '26.
- attends_eventAug 31, 2026
Sibionics group attended event IDF-WPR, ADC and Metabolic Diseases 2026 congress on Aug 21st '26.
SiBionics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SiBionics's valuation, stock price, and market status.
Is SiBionics a public or private company?
SiBionics is a private company.
What is the current stock price of SiBionics?
SiBionics is a private company with no public stock price. No recent secondary market data is available.
How much is SiBionics worth (valuation)?
Valuation information for SiBionics is not publicly available.
Can I buy SiBionics stock?
SiBionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SiBionics's last funding round?
SiBionics's most recent funding round was Series D on December 21, 2022.
Who are the main investors in SiBionics?
Key investors in SiBionics include Shenzhen Dachen Caizhi Venture Capital Management, Source Code Capital, CPE.
Will SiBionics IPO soon?
No public IPO plans have been announced for SiBionics.
How can I track SiBionics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SiBionics's secondary market activity and sign up for updates.